Activated partial thromboplastin time abnormal
(UMLS:C0853633)
- UMLS ID:
- C0853633
- MeSH ID:
- N/A
Synonym(s)
1.
Activated partial thromboplastin time abnormal
Associated Drug(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Dabigatran | FAERS: 26 | US FAERS | |
| 2 | reviparin | FAERS: 9 | US FAERS | |
| 3 | Rivaroxaban | FAERS: 5 | US FAERS | |
| 4 | Acetaminophen | FAERS: 3 | US FAERS | |
| 5 | Isotretinoin | FAERS: 3 | US FAERS | |
| 6 | Sevoflurane | FAERS: 3 | OFFSIDES US FAERS | |
| 7 | Clozapine | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance OFFSIDES US FAERS | |
| 8 | Dasatinib | FAERS: 2 | US FAERS | |
| 9 | Warfarin | FAERS: 2 | US FAERS | |
| 10 | lepirudin | FAERS: 2 | US FAERS | |
| 11 | Aprotinin | FAERS: 1 | US FAERS | |
| 12 | Azithromycin | FAERS: 1 | US FAERS | |
| 13 | Canagliflozin | FAERS: 1 | US FAERS | |
| 14 | Celecoxib | FAERS: 1 | US FAERS | |
| 15 | Docetaxel | FAERS: 1 | US FAERS | |
| 16 | Fluoxetine | FAERS: 1 | US FAERS | |
| 17 | MDV 3100 | FAERS: 1 | US FAERS | |
| 18 | Prasugrel Hydrochloride | FAERS: 1 | US FAERS | |
| 19 | Propylthiouracil | FAERS: 1 | US FAERS | |
| 20 | Tigecycline | FAERS: 1 | US FAERS | |
| 21 | apixaban | FAERS: 1 | US FAERS | |
| 22 | argatroban | FAERS: 1 | OFFSIDES US FAERS | |
| 23 | gemcitabine | FAERS: 1 | US FAERS | |
| 24 | regorafenib | FAERS: 1 | US FAERS | |
| 25 | Bortezomib | OFFSIDES | ||
| 26 | Cytarabine | OFFSIDES | ||
| 27 | Daunorubicin | OFFSIDES | ||
| 28 | Doxepin | OFFSIDES | ||
| 29 | Dronabinol | OFFSIDES | ||
| 30 | Mercaptopurine | OFFSIDES | ||
| 31 | Phenprocoumon | OFFSIDES | ||
| 32 | Pindolol | OFFSIDES | ||
| 33 | Ticarcillin | OFFSIDES | ||
| 34 | Tolterodine Tartrate | OFFSIDES | ||
| 35 | Tretinoin | OFFSIDES | ||
| 36 | Varenicline | OFFSIDES | ||
| 37 | fosfluconazole | OFFSIDES | ||
| 38 | sivelestat | OFFSIDES |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.